Cadila Healthcare gains on establishment inspection report for Ahmedabad facility - (Business Standard via NewsPoints Desk)

  • Shares in Cadila Healthcare rose as much as 4 percent after the company received an establishment inspection report from the FDA for its Indian facility in Ahmedabad, as reported Business Line reported Friday.

  • The drugmaker said the FDA inspection was conducted in January.

  • Cadila cautioned that the facility is a separate entity, and it does not form part of the Moraiya formulations manufacturing facility.

To read more NewsPoints articles, click here.

Reference Articles